Currently, there is no evidence linking changes in the expression of BRF1 to human cancers [6]; however, BRF2 has been shown to be overexpressed in many malignancies and plays a vital role in carcinogenesis [7, 8]. This evidence concerns the gene BRF2 and cancer.